Sector wide call here by GBA-- Charging stocks back in favor. People Also Watch Symbol Last Price Change % Change BLNK Blink Charging Co. 35.91 +1.78 +5.22% INSG Inseego Corp. 9.14 +0.56 +6.53% RMO Romeo Power, Inc. 6.77 +0.06 +0.89% FUV Arcimoto, Inc. 17.64 +0.17 +0.95% CHPT ChargePoint Holdings, Inc. 23.95 +0.73 +3.14%
ELMS with a business update and another nice rise. i gave up trying to buy the bottom and rebought on the rise a day ago or so, but so far ok choice: https://www.globenewswire.com/news-...nd-Partners-Ahead-of-Start-of-Production.html Electric Last Mile Solutions Inc NASDAQ: ELMS 9.48 USD +0.47 (5.22%)today Aug 5, 10:03 AM EDT
Genius Sports Limited (GENI)- popped a quick 50 cents just now NYSE - Nasdaq Real Time Price. Currency in USD 16.48+0.62 (+3.91%) As of 10:08AM EDT.
There wasn't a whole lot in that update! I'm probably guilty of knowing too much now about this company but one aspect that I do wonder about is their logistics. One reason why they are so cost efficient with this Van is the chassis is already built in China for some other vehicle. And shipped over. So now with 50 Vans on order that's no problem but if a huge order came in getting those chassis over in time... That's an important part of this company. They want to be on the good side of China... And I think they do have contacts and they would want to have some shipping pull<-- That I don't know. It helps to have friends with tankers.
THEORY. If DraftKing can pull this off and have a huge earnings report.... The wall st bets and stock twits and Robin Hoods will run it. I really think this might hit $57 tomorrow.
re: ELMS. i've read as well and they have a lot of timelines to hit for this to do well, so right now i'm just thinking in the short term. i was trying to catch its recovery--which i missed a fair bit of. looks like they're pushing the PR and the stock is probably battling shorts, though i don't have a feel on how much short interest they have here.
EVFM-- Here's the way to play it. Buy this Aug 10th Evofem Biosciences to Report Second Quarter 2021 Results and Provide Corporate Update on Wednesday, August 11, 2021 There is stuff to update. Remember we have a product on the market so Phexxi Sales?.... But we are waiting for a big trial. News on that being wrapped up... About Evofem Biosciences Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company launched its first FDA-approved commercial product,Phexxi®(lactic acid, citric acid and potassium bitartrate), in the United States in September 2020. The Company is evaluating lead product candidate EVO100 for the prevention of urogenital Chlamydia trachomatisand Neisseria gonorrhoeaei nfection in women in the ongoing Phase 3 clinical trial,'EVOGUARD.'